Norwegian Conference for Hereditary Neuromuscular Disorders

We’re proud to share that Pharmatest will participate in the Norwegian Conference for Hereditary Neuromuscular Disorders 2025, a premier gathering of clinicians, researchers, and patient advocates dedicated to advancing care and innovation in rare neuromuscular diseases. The conference offers a unique platform to explore cutting-edge diagnostics, therapeutic strategies, and collaborative research models.

You can meet Dr Kalervo Väänänen to discuss our research models. We are eager to explore new partnerships that will shape the future of rare disease research.

RareDisease Musculoskeletal NeuromuscularDisorders CRO Tromsø2025

See the info on LinkedIn.